Brunsvig, P. F., Guren, T. K., Nyakas, M., Steinfeldt-Reisse, C. H., Rasch, W., Kyte, J. A., . . . Inderberg, E. M. (2020). Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer. Front Immunol.
Chicago Style CitationBrunsvig, Paal F., et al. "Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer." Front Immunol 2020.
MLA CitationBrunsvig, Paal F., et al. "Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer." Front Immunol 2020.
Warning: These citations may not always be 100% accurate.